Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

Self-stigma was associated with higher dropout rates, engagement, and weight loss among individuals who completed a weight loss program.

State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...

Researchers at Henry Ford Health, collaborating with WeightWatchers International, report that more than 40% of individuals ...

HOUSTON — Dr. Aplin has a special offer for Great Day Viewers...schedule an appointment with Optimal Body Weight Loss by ...

Nearly half of participants in a weight loss program who initiated an antiobesity medication and who consumed alcohol ...

Engineers designed a new type of gastric balloon that can be inflated and deflated as needed. It could offer an alternative for people who don't want to undergo more invasive treatments such as ...

A fitness pro breaks down his one-month walking workout for weight loss, combining classic cardio with strength training.

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid, and the director of WVU Medicine’s medical weight ...

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

West Virginia’s Public Employee Insurance Agency (PEIA) is in a bind.  Medical inflation continues to drive up health care costs and the PEIA finance board is looking for ways to save money while ...